XML 59 R46.htm IDEA: XBRL DOCUMENT
v3.19.2

Condensed Consolidating financial statements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Condensed Consolidating Statements of Operations | Condensed Consolidating Statements of Operations
For the three months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient services revenues |  | $ | — |  |  | $ | 1,781,066 |  |  | $ | 1,014,869 |  |  | $ | (61,870 | ) |  | $ | 2,734,065 |
Provision for uncollectible accounts |  | — |  |  | (7,246 | ) |  | (3,003 | ) |  | — |  |  | (10,249 | )
Net patient service revenues |  | — |  |  | 1,773,820 |  |  | 1,011,866 |  |  | (61,870 | ) |  | 2,723,816 |
Other revenues |  | 207,299 |  |  | 115,226 |  |  | 37,035 |  |  | (240,671 | ) |  | 118,889 |
Total net revenues |  | 207,299 |  |  | 1,889,046 |  |  | 1,048,901 |  |  | (302,541 | ) |  | 2,842,705 |
Operating expenses |  | 160,464 |  |  | 1,673,331 |  |  | 849,565 |  |  | (302,541 | ) |  | 2,380,819 |
Operating income |  | 46,835 |  |  | 215,715 |  |  | 199,336 |  |  | — |  |  | 461,886 |
Debt expense |  | (144,896 | ) |  | (52,762 | ) |  | (11,217 | ) |  | 65,049 |  |  | (143,826 | )
Other income, net |  | 102,059 |  |  | 2,716 |  |  | 8,958 |  |  | (108,090 | ) |  | 5,643 |
Income tax expense |  | 627 |  |  | 63,930 |  |  | 11,381 |  |  | — |  |  | 75,938 |
Equity earnings in subsidiaries |  | 270,180 |  |  | 168,441 |  |  | — |  |  | (438,621 | ) |  | — |
Net income from continuing operations |  | 273,551 |  |  | 270,180 |  |  | 185,696 |  |  | (481,662 | ) |  | 247,765 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 36,351 |  |  | 43,041 |  |  | 79,392 |
Net income |  | 273,551 |  |  | 270,180 |  |  | 222,047 |  |  | (438,621 | ) |  | 327,157 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (53,606 | ) |  | (53,606 | )
Net income attributable to DaVita Inc. |  | $ | 273,551 |  |  | $ | 270,180 |  |  | $ | 222,047 |  |  | $ | (492,227 | ) |  | $ | 273,551 |
For the three months ended June 30, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient service revenues |  | $ | — |  |  | $ | 1,831,545 |  |  | $ | 936,646 |  |  | $ | (49,788 | ) |  | $ | 2,718,403 |
Provision for uncollectible accounts |  | — |  |  | (27,159 | ) |  | (22,247 | ) |  | — |  |  | (49,406 | )
Net patient service revenues |  | — |  |  | 1,804,386 |  |  | 914,399 |  |  | (49,788 | ) |  | 2,668,997 |
Other revenues |  | 205,317 |  |  | 214,266 |  |  | 43,137 |  |  | (244,764 | ) |  | 217,956 |
Total net revenues |  | 205,317 |  |  | 2,018,652 |  |  | 957,536 |  |  | (294,552 | ) |  | 2,886,953 |
Operating expenses and charges |  | 145,649 |  |  | 1,850,377 |  |  | 747,287 |  |  | (294,552 | ) |  | 2,448,761 |
Operating income |  | 59,668 |  |  | 168,275 |  |  | 210,249 |  |  | — |  |  | 438,192 |
Debt expense |  | (120,814 | ) |  | (52,363 | ) |  | (9,274 | ) |  | 62,759 |  |  | (119,692 | )
Other income, net |  | 105,344 |  |  | 2,856 |  |  | 4,440 |  |  | (110,646 | ) |  | 1,994 |
Income tax expense |  | 13,257 |  |  | 40,019 |  |  | 30,592 |  |  | — |  |  | 83,868 |
Equity earnings in subsidiaries |  | 236,335 |  |  | 157,586 |  |  | — |  |  | (393,921 | ) |  | — |
Net income from continuing operations |  | 267,276 |  |  | 236,335 |  |  | 174,823 |  |  | (441,808 | ) |  | 236,626 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 21,809 |  |  | 47,887 |  |  | 69,696 |
Net income |  | 267,276 |  |  | 236,335 |  |  | 196,632 |  |  | (393,921 | ) |  | 306,322 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (39,046 | ) |  | (39,046 | )
Net income attributable to DaVita Inc. |  | $ | 267,276 |  |  | $ | 236,335 |  |  | $ | 196,632 |  |  | $ | (432,967 | ) |  | $ | 267,276 |
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient services revenues |  | $ | — |  |  | $ | 3,558,312 |  |  | $ | 1,933,473 |  |  | $ | (122,568 | ) |  | $ | 5,369,217 |
Provision for uncollectible accounts |  | — |  |  | (11,216 | ) |  | (4,496 | ) |  | — |  |  | (15,712 | )
Net patient service revenues |  | — |  |  | 3,547,096 |  |  | 1,928,977 |  |  | (122,568 | ) |  | 5,353,505 |
Other revenues |  | 396,135 |  |  | 226,367 |  |  | 72,654 |  |  | (462,844 | ) |  | 232,312 |
Total net revenues |  | 396,135 |  |  | 3,773,463 |  |  | 2,001,631 |  |  | (585,412 | ) |  | 5,585,817 |
Operating expenses and charges |  | 304,123 |  |  | 3,333,784 |  |  | 1,730,929 |  |  | (585,412 | ) |  | 4,783,424 |
Operating income |  | 92,012 |  |  | 439,679 |  |  | 270,702 |  |  | — |  |  | 802,393 |
Debt expense |  | (278,491 | ) |  | (105,241 | ) |  | (21,936 | ) |  | 130,323 |  |  | (275,345 | )
Other income, net |  | 212,257 |  |  | 5,312 |  |  | 18,069 |  |  | (223,055 | ) |  | 12,583 |
Income tax expense |  | 7,653 |  |  | 110,474 |  |  | 14,557 |  |  | — |  |  | 132,684 |
Equity earnings in subsidiaries |  | 404,715 |  |  | 175,439 |  |  | — |  |  | (580,154 | ) |  | — |
Net income from continuing operations |  | 422,840 |  |  | 404,715 |  |  | 252,278 |  |  | (672,886 | ) |  | 406,947 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 16,965 |  |  | 92,732 |  |  | 109,697 |
Net income |  | 422,840 |  |  | 404,715 |  |  | 269,243 |  |  | (580,154 | ) |  | 516,644 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (93,804 | ) |  | (93,804 | )
Net income attributable to DaVita Inc. |  | $ | 422,840 |  |  | $ | 404,715 |  |  | $ | 269,243 |  |  | $ | (673,958 | ) |  | $ | 422,840 |
For the six months ended June 30, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient services revenues |  | $ | — |  |  | $ | 3,621,733 |  |  | $ | 1,785,047 |  |  | $ | (97,303 | ) |  | $ | 5,309,477 |
Provision for uncollectible accounts |  | — |  |  | (17,531 | ) |  | (6,330 | ) |  | — |  |  | (23,861 | )
Net patient service revenues |  | — |  |  | 3,604,202 |  |  | 1,778,717 |  |  | (97,303 | ) |  | 5,285,616 |
Other revenues |  | 400,882 |  |  | 419,226 |  |  | 114,070 |  |  | (483,397 | ) |  | 450,781 |
Total net revenues |  | 400,882 |  |  | 4,023,428 |  |  | 1,892,787 |  |  | (580,700 | ) |  | 5,736,397 |
Operating expenses and charges |  | 279,005 |  |  | 3,641,471 |  |  | 1,547,743 |  |  | (580,700 | ) |  | 4,887,519 |
Operating income |  | 121,877 |  |  | 381,957 |  |  | 345,044 |  |  | — |  |  | 848,878 |
Debt expense |  | (235,148 | ) |  | (104,560 | ) |  | (16,649 | ) |  | 123,149 |  |  | (233,208 | )
Other income, net |  | 209,425 |  |  | 5,379 |  |  | 10,144 |  |  | (218,372 | ) |  | 6,576 |
Income tax expense |  | 27,644 |  |  | 88,962 |  |  | 37,999 |  |  | — |  |  | 154,605 |
Equity earnings in subsidiaries |  | 377,452 |  |  | 183,638 |  |  | — |  |  | (561,090 | ) |  | — |
Net income from continuing operations |  | 445,962 |  |  | 377,452 |  |  | 300,540 |  |  | (656,313 | ) |  | 467,641 |
Net (loss) income from discontinued operations, net of tax |  | — |  |  | — |  |  | (31,313 | ) |  | 95,223 |  |  | 63,910 |
Net income |  | 445,962 |  |  | 377,452 |  |  | 269,227 |  |  | (561,090 | ) |  | 531,551 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (85,589 | ) |  | (85,589 | )
Net income attributable to DaVita Inc. |  | $ | 445,962 |  |  | $ | 377,452 |  |  | $ | 269,227 |  |  | $ | (646,679 | ) |  | $ | 445,962 |
Condensed Consolidating Statements of Income
For the six months ended June 30, 2019 |  | Consolidated Total |  | Physician Groups |  | Unrestricted Subsidiaries |  | Company and Restricted Subsidiaries(1)
Patient service operating revenues |  | $ | 5,369,217 |  |  | $ | — |  |  | $ | — |  |  | $ | 5,369,217 |
Provision for uncollectible accounts |  | (15,712 | ) |  | — |  |  | — |  |  | (15,712 | )
Net patient service operating revenues |  | 5,353,505 |  |  | — |  |  | — |  |  | 5,353,505 |
Other revenues |  | 232,312 |  |  | — |  |  | — |  |  | 232,312 |
Total net operating revenues |  | 5,585,817 |  |  | — |  |  | — |  |  | 5,585,817 |
Operating expenses |  | 4,783,424 |  |  | — |  |  | — |  |  | 4,783,424 |
Operating income |  | 802,393 |  |  | — |  |  | — |  |  | 802,393 |
Debt expense |  | (275,345 | ) |  | — |  |  | — |  |  | (275,345 | )
Other income |  | 12,583 |  |  | — |  |  | — |  |  | 12,583 |
Income tax expense |  | 132,684 |  |  | — |  |  | — |  |  | 132,684 |
Net income from continuing operations |  | 406,947 |  |  | — |  |  | — |  |  | 406,947 |
Net income from discontinued operations, net of tax |  | 109,697 |  |  | 12,706 |  |  | 249 |  |  | 96,742 |
Net income |  | 516,644 |  |  | 12,706 |  |  | 249 |  |  | 503,689 |
Less: Net income attributable to noncontrolling interests |  | (93,804 | ) |  | (1,255 | ) |  | — |  |  | (92,549 | )
Net income attributable to DaVita Inc. |  | $ | 422,840 |  |  | $ | 11,451 |  |  | $ | 249 |  |  | $ | 411,140 |
(1) After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Statements of Comprehensive Income | Condensed Consolidating Statements of Comprehensive Income
For the three months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 273,551 |  |  | $ | 270,180 |  |  | $ | 222,047 |  |  | $ | (438,621 | ) |  | $ | 327,157 |
Other comprehensive income |  | 1,575 |  |  | — |  |  | 12,365 |  |  | — |  |  | 13,940 |
Total comprehensive income |  | 275,126 |  |  | 270,180 |  |  | 234,412 |  |  | (438,621 | ) |  | 341,097 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (53,606 | ) |  | (53,606 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 275,126 |  |  | $ | 270,180 |  |  | $ | 234,412 |  |  | $ | (492,227 | ) |  | $ | 287,491 |
For the three months ended June 30, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 267,276 |  |  | $ | 236,335 |  |  | $ | 196,632 |  |  | $ | (393,921 | ) |  | $ | 306,322 |
Other comprehensive income (loss) |  | 1,269 |  |  | — |  |  | (50,529 | ) |  | — |  |  | (49,260 | )
Total comprehensive income |  | 268,545 |  |  | 236,335 |  |  | 146,103 |  |  | (393,921 | ) |  | 257,062 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (39,046 | ) |  | (39,046 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 268,545 |  |  | $ | 236,335 |  |  | $ | 146,103 |  |  | $ | (432,967 | ) |  | $ | 218,016 |
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 422,840 |  |  | $ | 404,715 |  |  | $ | 269,243 |  |  | $ | (580,154 | ) |  | $ | 516,644 |
Other comprehensive income (loss) |  | 2,601 |  |  | — |  |  | (1,288 | ) |  | — |  |  | 1,313 |
Total comprehensive income |  | 425,441 |  |  | 404,715 |  |  | 267,955 |  |  | (580,154 | ) |  | 517,957 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (93,804 | ) |  | (93,804 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 425,441 |  |  | $ | 404,715 |  |  | $ | 267,955 |  |  | $ | (673,958 | ) |  | $ | 424,153 |
For the six months ended June 30, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 445,962 |  |  | $ | 377,452 |  |  | $ | 269,227 |  |  | $ | (561,090 | ) |  | $ | 531,551 |
Other comprehensive income (loss) |  | 3,856 |  |  | — |  |  | (30,648 | ) |  | — |  |  | (26,792 | )
Total comprehensive income |  | 449,818 |  |  | 377,452 |  |  | 238,579 |  |  | (561,090 | ) |  | 504,759 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (85,589 | ) |  | (85,589 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 449,818 |  |  | $ | 377,452 |  |  | $ | 238,579 |  |  | $ | (646,679 | ) |  | $ | 419,170 |
Condensed Consolidating Statements of Comprehensive Income
For the six months ended June 30, 2019 |  | Consolidated Total |  | Physician Groups |  | Unrestricted Subsidiaries |  | Company and Restricted Subsidiaries(1)
Net income |  | $ | 516,644 |  |  | $ | 12,706 |  |  | $ | 249 |  |  | $ | 503,689 |
Other comprehensive income |  | 1,313 |  |  | — |  |  | — |  |  | 1,313 |
Total comprehensive income |  | 517,957 |  |  | 12,706 |  |  | 249 |  |  | 505,002 |
Less: Comprehensive income attributable to the noncontrolling interests |  | (93,804 | ) |  | (1,255 | ) |  | — |  |  | (92,549 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 424,153 |  |  | $ | 11,451 |  |  | $ | 249 |  |  | $ | 412,453 |
(1) After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Balance Sheets | Condensed Consolidating Balance Sheets
As of June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash and cash equivalents |  | $ | 3,374,887 |  |  | $ | — |  |  | $ | 200,751 |  |  | $ | — |  |  | $ | 3,575,638 |
Restricted cash and equivalents |  | 1,007 |  |  | 12,181 |  |  | 93,584 |  |  | — |  |  | 106,772 |
Accounts receivable, net |  | — |  |  | 1,352,844 |  |  | 657,957 |  |  | — |  |  | 2,010,801 |
Other current assets |  | 37,185 |  |  | 545,881 |  |  | 114,352 |  |  | — |  |  | 697,418 |
Total current assets |  | 3,413,079 |  |  | 1,910,906 |  |  | 1,066,644 |  |  | — |  |  | 6,390,629 |
Property and equipment, net |  | 501,219 |  |  | 1,613,193 |  |  | 1,290,903 |  |  | — |  |  | 3,405,315 |
Operating lease right-of-use assets |  | 105,137 |  |  | 1,636,360 |  |  | 1,049,388 |  |  | — |  |  | 2,790,885 |
Intangible assets, net |  | 107 |  |  | 37,272 |  |  | 83,195 |  |  | — |  |  | 120,574 |
Investments in subsidiaries |  | 11,304,840 |  |  | 3,184,913 |  |  | — |  |  | (14,489,753 | ) |  | — |
Intercompany receivables |  | — |  |  | 1,563,270 |  |  | 1,483,874 |  |  | (3,047,144 | ) |  | — |
Other long-term assets and investments |  | 80,491 |  |  | 81,567 |  |  | 196,113 |  |  | — |  |  | 358,171 |
Goodwill |  | — |  |  | 4,821,054 |  |  | 2,044,332 |  |  | — |  |  | 6,865,386 |
Total assets |  | $ | 15,404,873 |  |  | $ | 14,848,535 |  |  | $ | 7,214,449 |  |  | $ | (17,536,897 | ) |  | $ | 19,930,960 |
Current liabilities |  | $ | 3,767,482 |  |  | $ | 1,348,798 |  |  | $ | 590,664 |  |  | $ | — |  |  | $ | 5,706,944 |
Intercompany payables |  | 1,710,121 |  |  | — |  |  | 1,337,023 |  |  | (3,047,144 | ) |  | — |
Long-term operating leases liabilities |  | 133,349 |  |  | 1,550,461 |  |  | 1,005,439 |  |  | — |  |  | 2,689,249 |
Long-term debt and other long-term liabilities |  | 5,103,876 |  |  | 644,436 |  |  | 357,653 |  |  | — |  |  | 6,105,965 |
Noncontrolling interests subject to put provisions |  | 640,747 |  |  | — |  |  | — |  |  | 544,986 |  |  | 1,185,733 |
Total DaVita Inc. shareholders' equity |  | 4,049,298 |  |  | 11,304,840 |  |  | 3,184,913 |  |  | (14,489,753 | ) |  | 4,049,298 |
Noncontrolling interests not subject to put provisions |  | — |  |  | — |  |  | 738,757 |  |  | (544,986 | ) |  | 193,771 |
Total equity |  | 4,049,298 |  |  | 11,304,840 |  |  | 3,923,670 |  |  | (15,034,739 | ) |  | 4,243,069 |
Total liabilities and equity |  | $ | 15,404,873 |  |  | $ | 14,848,535 |  |  | $ | 7,214,449 |  |  | $ | (17,536,897 | ) |  | $ | 19,930,960 |
As of December 31, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash and cash equivalents |  | $ | 60,653 |  |  | $ | — |  |  | $ | 262,385 |  |  | $ | — |  |  | $ | 323,038 |
Restricted cash and equivalents |  | 1,005 |  |  | 12,048 |  |  | 79,329 |  |  | — |  |  | 92,382 |
Accounts receivable, net |  | — |  |  | 1,264,290 |  |  | 594,318 |  |  | — |  |  | 1,858,608 |
Other current assets |  | 37,185 |  |  | 601,318 |  |  | 122,063 |  |  | — |  |  | 760,566 |
Current assets held for sale |  | — |  |  | — |  |  | 5,389,565 |  |  | — |  |  | 5,389,565 |
Total current assets |  | 98,843 |  |  | 1,877,656 |  |  | 6,447,660 |  |  | — |  |  | 8,424,159 |
Property and equipment, net |  | 491,462 |  |  | 1,624,835 |  |  | 1,277,372 |  |  | — |  |  | 3,393,669 |
Intangible assets, net |  | 153 |  |  | 42,933 |  |  | 75,760 |  |  | — |  |  | 118,846 |
Investments in subsidiaries |  | 10,102,750 |  |  | 3,371,450 |  |  | — |  |  | (13,474,200 | ) |  | — |
Intercompany receivables |  | 3,419,448 |  |  | 259,573 |  |  | 1,788,043 |  |  | (5,467,064 | ) |  | — |
Other long-term assets and investments |  | 53,385 |  |  | 80,537 |  |  | 197,696 |  |  | — |  |  | 331,618 |
Goodwill |  | — |  |  | 4,812,365 |  |  | 2,029,595 |  |  | — |  |  | 6,841,960 |
Total assets |  | $ | 14,166,041 |  |  | $ | 12,069,349 |  |  | $ | 11,816,126 |  |  | $ | (18,941,264 | ) |  | $ | 19,110,252 |
Current liabilities |  | $ | 1,945,943 |  |  | $ | 1,251,534 |  |  | $ | 449,925 |  |  | $ | — |  |  | $ | 3,647,402 |
Current liabilities held for sale |  | — |  |  | — |  |  | 1,243,759 |  |  | — |  |  | 1,243,759 |
Intercompany payables |  | — |  |  | — |  |  | 5,467,064 |  |  | (5,467,064 | ) |  | — |
Long-term debt and other long-term liabilities |  | 7,918,581 |  |  | 715,065 |  |  | 552,406 |  |  | — |  |  | 9,186,052 |
Noncontrolling interests subject to put provisions |  | 598,075 |  |  | — |  |  | — |  |  | 526,566 |  |  | 1,124,641 |
Total DaVita Inc. shareholders' equity |  | 3,703,442 |  |  | 10,102,750 |  |  | 3,371,450 |  |  | (13,474,200 | ) |  | 3,703,442 |
Noncontrolling interests not subject to put provisions |  | — |  |  | — |  |  | 731,522 |  |  | (526,566 | ) |  | 204,956 |
Total equity |  | 3,703,442 |  |  | 10,102,750 |  |  | 4,102,972 |  |  | (14,000,766 | ) |  | 3,908,398 |
Total liabilities and equity |  | $ | 14,166,041 |  |  | $ | 12,069,349 |  |  | $ | 11,816,126 |  |  | $ | (18,941,264 | ) |  | $ | 19,110,252 |
Condensed Consolidating Balance Sheets
As of June 30, 2019 |  | Consolidated Total |  | Physician Groups |  | Unrestricted Subsidiaries |  | Company and Restricted Subsidiaries(1)
Cash and cash equivalents |  | $ | 3,575,638 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,575,638 |
Restricted cash and equivalents |  | 106,772 |  |  | — |  |  | — |  |  | 106,772 |
Accounts receivable, net |  | 2,010,801 |  |  | — |  |  | — |  |  | 2,010,801 |
Other current assets |  | 697,418 |  |  | — |  |  | — |  |  | 697,418 |
Total current assets |  | 6,390,629 |  |  | — |  |  | — |  |  | 6,390,629 |
Property and equipment, net |  | 3,405,315 |  |  | — |  |  | — |  |  | 3,405,315 |
Operating lease right-of-use assets |  | 2,790,885 |  |  | — |  |  | — |  |  | 2,790,885 |
Amortizable intangibles, net |  | 120,574 |  |  | — |  |  | — |  |  | 120,574 |
Other long-term assets |  | 358,171 |  |  | — |  |  | — |  |  | 358,171 |
Goodwill |  | 6,865,386 |  |  | — |  |  | — |  |  | 6,865,386 |
Total assets |  | $ | 19,930,960 |  |  | $ | — |  |  | $ | — |  |  | $ | 19,930,960 |
Current liabilities |  | $ | 5,706,944 |  |  | $ | — |  |  | $ | — |  |  | $ | 5,706,944 |
Long-term operating leases liabilities |  | 2,689,249 |  |  | — |  |  | — |  |  | 2,689,249 |
Long-term debt and other long-term liabilities |  | 6,105,965 |  |  | — |  |  | — |  |  | 6,105,965 |
Noncontrolling interests subject to put provisions |  | 1,185,733 |  |  | — |  |  | — |  |  | 1,185,733 |
Total DaVita Inc. shareholders’ equity |  | 4,049,298 |  |  | — |  |  | — |  |  | 4,049,298 |
Noncontrolling interests not subject to put provisions |  | 193,771 |  |  | — |  |  | — |  |  | 193,771 |
Shareholders’ equity |  | 4,243,069 |  |  | — |  |  | — |  |  | 4,243,069 |
Total liabilities and shareholder’s equity |  | $ | 19,930,960 |  |  | $ | — |  |  | $ | — |  |  | $ | 19,930,960 |
(1) After elimination of the unrestricted subsidiaries and the physician groups.
Condensed Consolidating Statements of Cash Flows | Condensed Consolidating Statements of Cash Flows
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 422,840 |  |  | $ | 404,715 |  |  | $ | 269,243 |  |  | $ | (580,154 | ) |  | $ | 516,644 |
Changes in operating assets and liabilities and non-cash items included in net income |  | (292,988 | ) |  | (210,545 | ) |  | 157,850 |  |  | 580,154 |  |  | 234,471 |
Net cash provided by operating activities |  | 129,852 |  |  | 194,170 |  |  | 427,093 |  |  | — |  |  | 751,115 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  | (63,037 | ) |  | (174,483 | ) |  | (136,398 | ) |  | — |  |  | (373,918 | )
Acquisitions |  | — |  |  | (8,975 | ) |  | (56,995 | ) |  | — |  |  | (65,970 | )
Proceeds from asset and business sales |  | 3,824,509 |  |  | 33 |  |  | 26,839 |  |  | — |  |  | 3,851,381 |
Proceeds (purchases) from investment sales and other items, net |  | 729 |  |  | (6,560 | ) |  | (2,970 | ) |  | — |  |  | (8,801 | )
Net cash provided by (used in) investing activities |  | 3,762,201 |  |  | (189,985 | ) |  | (169,524 | ) |  | — |  |  | 3,402,692 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt and related financing costs, net |  | (1,152,510 | ) |  | (5,270 | ) |  | (6,329 | ) |  | — |  |  | (1,164,109 | )
Intercompany borrowing (payments) |  | 656,704 |  |  | 1,218 |  |  | (657,922 | ) |  | — |  |  | — |
Other items |  | (82,011 | ) |  | — |  |  | (64,433 | ) |  | — |  |  | (146,444 | )
Net cash used in financing activities |  | (577,817 | ) |  | (4,052 | ) |  | (728,684 | ) |  | — |  |  | (1,310,553 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | (77 | ) |  | — |  |  | (77 | )
Net increase (decrease) in cash, cash equivalents and restricted cash |  | 3,314,236 |  |  | 133 |  |  | (471,192 | ) |  | — |  |  | 2,843,177 |
Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations |  | — |  |  | — |  |  | (423,813 | ) |  | — |  |  | (423,813 | )
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations |  | 3,314,236 |  |  | 133 |  |  | (47,379 | ) |  | — |  |  | 3,266,990 |
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year |  | 61,658 |  |  | 12,048 |  |  | 341,714 |  |  | — |  |  | 415,420 |
Cash, cash equivalents and restricted cash of continuing operations at end of the period |  | $ | 3,375,894 |  |  | $ | 12,181 |  |  | $ | 294,335 |  |  | $ | — |  |  | $ | 3,682,410 |
For the six months ended June 30, 2018 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 445,962 |  |  | $ | 377,452 |  |  | $ | 269,227 |  |  | $ | (561,090 | ) |  | $ | 531,551 |
Changes in operating assets and liabilities and non-cash items included in net income |  | (361,134 | ) |  | 31,554 |  |  | 161,514 |  |  | 561,090 |  |  | 393,024 |
Net cash provided by operating activities |  | 84,828 |  |  | 409,006 |  |  | 430,741 |  |  | — |  |  | 924,575 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  | (77,169 | ) |  | (216,103 | ) |  | (180,705 | ) |  | — |  |  | (473,977 | )
Acquisitions |  | — |  |  | (6,916 | ) |  | (82,549 | ) |  | — |  |  | (89,465 | )
Proceeds from asset and business sales |  | — |  |  | 28,546 |  |  | 87,695 |  |  | — |  |  | 116,241 |
Proceeds (purchases) from investment sales and other items, net |  | 32,415 |  |  | (7,232 | ) |  | (2,046 | ) |  | — |  |  | 23,137 |
Net cash used in investing activities |  | (44,754 | ) |  | (201,705 | ) |  | (177,605 | ) |  | — |  |  | (424,064 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt and related financing costs, net |  | 584,500 |  |  | (4,398 | ) |  | (6,121 | ) |  | — |  |  | 573,981 |
Intercompany borrowing (payments) |  | 224,359 |  |  | (187,712 | ) |  | (36,647 | ) |  | — |  |  | — |
Other items |  | (804,245 | ) |  | (13,208 | ) |  | (62,437 | ) |  | — |  |  | (879,890 | )
Net cash provided by (used in) financing activities |  | 4,614 |  |  | (205,318 | ) |  | (105,205 | ) |  | — |  |  | (305,909 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | (3,473 | ) |  | — |  |  | (3,473 | )
Net increase in cash, cash equivalents and restricted cash |  | 44,688 |  |  | 1,983 |  |  | 144,458 |  |  | — |  |  | 191,129 |
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations |  | — |  |  | — |  |  | 229,901 |  |  | — |  |  | 229,901 |
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations |  | 44,688 |  |  | 1,983 |  |  | (85,443 | ) |  | — |  |  | (38,772 | )
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year |  | 150,307 |  |  | 9,384 |  |  | 359,229 |  |  | — |  |  | 518,920 |
Cash, cash equivalents and restricted cash of continuing operations at end of the period |  | $ | 194,995 |  |  | $ | 11,367 |  |  | $ | 273,786 |  |  | $ | — |  |  | $ | 480,148 |
Condensed Consolidating Statements of Cash Flows
For the six months ended June 30, 2019 |  | Consolidated Total |  | Physician Groups |  | Unrestricted Subsidiaries |  | Company and Restricted Subsidiaries(1)
Cash flows from operating activities: |  |  |  |  |  |  |  |
Net income |  | $ | 516,644 |  |  | $ | 12,706 |  |  | $ | 249 |  |  | $ | 503,689 |
Changes in operating and intercompany assets and liabilities and non-cash items included in net income |  | 234,471 |  |  | (4,607 | ) |  | (249 | ) |  | 239,327 |
Net cash provided by operating activities |  | 751,115 |  |  | 8,099 |  |  | — |  |  | 743,016 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  | (373,918 | ) |  | (846 | ) |  | — |  |  | (373,072 | )
Acquisitions |  | (65,970 | ) |  | — |  |  | — |  |  | (65,970 | )
Proceeds from asset and business sales |  | 3,851,381 |  |  | — |  |  | — |  |  | 3,851,381 |
Investments and other items |  | (8,801 | ) |  | (1,882 | ) |  | — |  |  | (6,919 | )
Net cash provided by (used in) investing activities |  | 3,402,692 |  |  | (2,728 | ) |  | — |  |  | 3,405,420 |
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt |  | (1,164,109 | ) |  | — |  |  | — |  |  | (1,164,109 | )
Intercompany |  | — |  |  | (247,175 | ) |  | — |  |  | 247,175 |
Other items |  | (146,444 | ) |  | — |  |  | — |  |  | (146,444 | )
Net cash used in financing activities |  | (1,310,553 | ) |  | (247,175 | ) |  | — |  |  | (1,063,378 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | (77 | ) |  | — |  |  | — |  |  | (77 | )
Net increase (decrease) in cash, cash equivalents and restricted cash |  | 2,843,177 |  |  | (241,804 | ) |  | — |  |  | 3,084,981 |
Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations |  | (423,813 | ) |  | (241,804 | ) |  | — |  |  | (182,009 | )
Net increase in cash, cash equivalents and restricted cash from continuing operations |  | 3,266,990 |  |  | — |  |  | — |  |  | 3,266,990 |
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year |  | 415,420 |  |  | — |  |  | — |  |  | 415,420 |
Cash, cash equivalents and restricted cash of continuing operations at end of the period |  | $ | 3,682,410 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,682,410 |
(1) After elimination of the unrestricted subsidiaries and the physician groups.

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration